These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6061929)
1. Xanthines: central nervous system reactions in allergic individuals. Six years' experience with a theophylline-noscapine preparation. Rudolph JA; Munch JC; Seinfeld BM Ann Allergy; 1967 Nov; 25(11):649-53. PubMed ID: 6061929 [No Abstract] [Full Text] [Related]
5. [Theophylline. A new look at an old drug]. Zugić M; Varagić VM Srp Arh Celok Lek; 1982 Feb; 110(2):211-31. PubMed ID: 7157077 [No Abstract] [Full Text] [Related]
6. [Central adverse effects of methylxanthines]. Defer G Therapie; 1992; 47(1):67-73. PubMed ID: 1523598 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacodynamic research on the action of nitrites on the central nervous system]. Velluda CC; Pop S; Ticşa I; Stroilă C; Csutak V; Mocanu R Fiziol Norm Patol; 1967; 13(2):171-6. PubMed ID: 6044986 [No Abstract] [Full Text] [Related]
8. [Methylxanthine preparations in the therapy of bronchial asthma]. Fedoseev GB; Kriakunov KN; Leĭchenko LV; Evartau EE Ter Arkh; 1987; 59(7):131-5. PubMed ID: 3313783 [No Abstract] [Full Text] [Related]
9. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets. Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356 [TBL] [Abstract][Full Text] [Related]
10. Aminophylline suppositories and sustained-release tablets compared in bronchospasm. Ross AE Practitioner; 1981 Jul; 225(1357):1061-2. PubMed ID: 7031630 [No Abstract] [Full Text] [Related]
11. TREATMENT OF BRONCHOSPASTIC STATES IN CHILDREN WITH A THEOPHYLLINE-NOSCAPINE FORMULATION. RUDOLPH JA; FRIEDLAND B Clin Med (Northfield); 1964 May; 71():853-61. PubMed ID: 15446162 [No Abstract] [Full Text] [Related]
12. [The semisynthetic production of pharmacologically active flavone derivatives. I. The pharmaco-toxicological properties of theophylline-rutozide (TR 1722)]. Dănilă G; Nechifor M Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):151-6. PubMed ID: 2075319 [TBL] [Abstract][Full Text] [Related]
13. [Study of chemically obtained derivatives of theophylline]. Lespagnol A; Debaert M; Blears A; Devergnies M; Cazin JC; Cazin M Ann Pharm Fr; 1973 Dec; 31(12):751-8. PubMed ID: 4804225 [No Abstract] [Full Text] [Related]
14. Oral theophylline and asthma. Taylor AJ N Z Med J; 1984 Oct; 97(766):722-3. PubMed ID: 6595559 [No Abstract] [Full Text] [Related]
15. [Theophylline and its derivatives]. Wrońska J; Droszcz W Pol Arch Med Wewn; 1985 Jan; 73(1):57-63. PubMed ID: 4022797 [No Abstract] [Full Text] [Related]
16. [The use of sustained release theophylline preparations in chronic bronchospastic diseases]. Nir I Harefuah; 1984 Mar; 106(5):235-6. PubMed ID: 6724423 [No Abstract] [Full Text] [Related]
17. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma. Trautlein JJ; Demers L; Esler V; Field E Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913 [TBL] [Abstract][Full Text] [Related]
18. The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics. Persson CG Agents Actions Suppl; 1983; 13():115-29. PubMed ID: 6346831 [No Abstract] [Full Text] [Related]
19. [Adverse-effects of theophylline on the central nervous system; clinical characteristics of theophylline-associated seizures]. Maegaki Y Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):593-6. PubMed ID: 10434728 [No Abstract] [Full Text] [Related]
20. [Comparison of two long-acting theophylline preparations in daily evening administration]. Holzer R Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]